Urinary Bladder Diseases clinical trials
The registry lists 62 studies for Urinary Bladder Diseases across more than 10 countries. 9 are recruiting or about to start. 10 of them are mainly about Urinary Bladder Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28. Counting its 10 narrower conditions too, such as Urinary Bladder Neoplasms: 3,410 studies, 744 open.
Get an email when these change. Save the Urinary Bladder Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
UroGen Pharma Ltd. (4) · Astellas Pharma Europe Ltd. (3) · Rainier Therapeutics (2) · Mansoura University (2) · Medical Enterprises Europe B.V. (2) · Astellas Pharma Europe B.V. (2) · H. Lee Moffitt Cancer Center and Research Institute (2) · Ludwig-Maximilians - University of Munich (1)
What is being tested here
Drugs under test in Urinary Bladder Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Enfortumab vedotin | 1 | 1 | 1 |
| Pembrolizumab | 1 | 1 | 1 |
| Mirabegron | 0 | 2 | 3 |
| Solifenacin | 0 | 1 | 2 |
| Vofatamab | 0 | 0 | 2 |
| Nivolumab | 0 | 0 | 1 |
| Sasanlimab | 0 | 0 | 1 |
| Amitriptyline | 0 | 1 | 1 |
| ASP3652 | 0 | 0 | 1 |
| Enzalutamide | 0 | 0 | 1 |
Drug classes tested here Immune checkpoint inhibitors 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Dec 2026Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab · The Netherlands Cancer Institute
- Jan 2027Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study · University of California, Los Angeles
Who these studies take
Of the 7 Urinary Bladder Diseases studies recruiting now, 5 (71%) set no upper age limit and 1 (14%) stop at 75 or younger. 1 (14%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (14%) | 1 (14%) |
| 18 | 7 (100%) | 7 (100%) |
| 30 | 7 (100%) | 7 (100%) |
| 40 | 7 (100%) | 7 (100%) |
| 50 | 7 (100%) | 7 (100%) |
| 65 | 7 (100%) | 7 (100%) |
| 75 | 6 (86%) | 6 (86%) |
| 85 | 5 (71%) | 5 (71%) |
Across all 62 studies, recruiting or not: 11% stop at 75 or younger and 6% at 65; 11% take children; 6% are for women only and 2% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 50 of 62. Browse all 62 → or search them.
- Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)RecruitingNCT07566156Phase 34 countries
- Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in ChildrenNot yet recruitingNCT06769854Phase 4
- The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)RecruitingNCT05726786Phase 31 country
- Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapyRecruitingNCT04442724Not applicable1 country
- Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human StudyRecruitingNCT06337942Not applicable1 country
- Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical InstillationRecruitingNCT067192321 country
- Infectious Complications After Cystectomy: A Prospective Observational StudyRecruitingNCT051536941 country
- Different Injection Site Maps & Intravesical Botulinum ToxinNot yet recruitingNCT06185218Not applicable
- Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.RecruitingNCT061673561 country
- INTIBIA Pivotal StudyActive, not recruitingNCT05250908Not applicable2 countries
- Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without RelatlimabActive, not recruitingNCT06237920Phase 21 country
- CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder CancerActive, not recruitingNCT039338261 country
- Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)CompletedNCT00124306Phase 32 countries
- Pediatric Urology Recovery After Surgery Endeavor (PURSUE)Active, not recruitingNCT032452421 country
- The COOKER-BLADDER TrialCompletedNCT05643963Not applicable1 country
- Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder CancerActive, not recruitingNCT05241340Phase 21 country
- Remote Access to Urinary Incontinence Treatment for Women VeteransCompletedNCT04237753Not applicable1 country
- Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder CancerCompletedNCT03081858Phase 1/21 country
- ECHO-012 Kosmos Bladder Clinical Validation StudyCompletedNCT06792851Not applicable1 country
- A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.CompletedNCT01638000Phase 333 countries
- A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)CompletedNCT01613586Phase 212 countries
- A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive BladderCompletedNCT01340027Phase 220 countries
- A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical PracticeCompletedNCT023207738 countries
- A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)CompletedNCT01908829Phase 331 countries
- Can VI-RADS/ADC Accurately Stage Bladder Cancer??Active, not recruitingNCT04167631Not applicable1 country
- A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)CompletedNCT023860722 countries
- Trimodality Treatment in Bladder CancerCompletedNCT063957011 country
- Osteoporosis, Trabecular Bone Score and Fracture Risk Assessment in Male Patients After Radical CystectomyCompletedNCT041532271 country
- A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial CarcinomaCompletedNCT04200963Phase 11 country
- Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the BladderTerminatedNCT02901548Phase 21 country
- Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy TreatmentCompletedNCT002102491 country
- Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans (DETTECH)CompletedNCT04161716Not applicable1 country
- A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder PainTerminatedNCT01060254Phase 22 countries
- Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible CystoscopyCompletedNCT04192474Not applicable2 countries
- Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)Status unknownNCT04922047Phase 1/21 country
- Eosinophilic Cystitis Mimicking Urothelial NeoplasiaCompletedNCT04914442
- A Trial of a Modified Cystoscopy Method to Reduce Pain PerceptionCompletedNCT03257293Not applicable1 country
- Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivityStatus unknownNCT034866391 country
- A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell CarcinomaTerminatedNCT03123055Phase 1/217 countries
- Falls and Balance of Patients With Parkinson's Disease With Urinary DisturbanceCompletedNCT038457251 country
- Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell CarcinomaTerminatedNCT02401542Phase 1/29 countries
- The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological CorrelationCompletedNCT03591367Not applicable1 country
- Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder CancerCompletedNCT02300610Phase 11 country
- Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic CystitisWithdrawnNCT00956176Not applicable
- Perioperative Multimodal Care for Cystectomy Frail PatientTerminatedNCT03065348Not applicable1 country
- Bladder Endometriosis: Evaluation in MRI of the Involvement of the Posterior Inferior WallCompletedNCT039067601 country
- Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the BladderTerminatedNCT01310803Phase 31 country
- Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder CancerTerminatedNCT01200992Phase 36 countries
- Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC PatientsCompletedNCT02307487Phase 21 country
- Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBCCompletedNCT01803295Not applicable4 countries